Damian Marron - TxCell
Staying in France, personalized cell-based immunotherapy developer TxCell has appointed Damian Marron as its new CEO, replacing Francois Meyer who has been appointed Executive Chairman of the Board of Directors.
Marron was previously CEO of Cytheris and before this CEO of Trophos. He has been Executive Vice President Corporate Development at NicOx.
Meyer said: “At this stage of TxCell’s development, it has been critical for us to appoint a CEO who has both a high level of experience at working in niche and orphan market places with unmet medical needs, as well as for both private and public companies.”